Cardinal Health (CAH) FY2021 results: revenue $162.5 billion, up 6.2% on the year
Cardinal Health Inc. (CAH) reported revenue of $162.5 billion for fiscal 2021, the year ended 30 June 2021, up 6.2% on the year before. Net income was $611 million, and diluted earnings per share $2.08. The figures are the company's own, from the 10-K it filed with the SEC on 16 August 2021.
Revenue
$162.5 billion
+6.2% on the year
FY2014FY2021
Operating margin
0.3%
-2.7% a year earlier
FY2014FY2021
Net income
$611 million
FY2014FY2021
Diluted EPS
$2.08
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Revenue
162,467
152,922
145,534
+6.2%
Cost of revenue
155,689
146,054
138,700
+6.6%
Gross profit
6,778
6,868
6,834
-1.3%
Gross margin
4.2%
4.5%
4.7%
Selling, general and administrative
4,533
4,572
4,480
-0.9%
Operating income
472
-4,098
2,060
Operating margin
0.3%
-2.7%
1.4%
Interest expense
180
238
294
-24.4%
Pre-tax income
323
-3,772
1,751
Income tax
-289
-79.0
386
Effective tax rate
-89.5%
n/a
22.0%
Net income
611
-3,696
1,363
Net margin
0.4%
-2.4%
0.9%
Diluted EPS
$2.08
-$12.61
$4.53
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
2,429
1,960
2,722
+23.9%
Capital expenditure
400
375
328
+6.7%
Free cash flow
2,029
1,585
2,394
+28.0%
Free cash flow margin
1.2%
1.0%
1.6%
Cash from investing
-378
493
338
Cash from financing
-1,317
-2,200
-2,293
Depreciation and amortisation
783
913
1,000
-14.2%
Share-based compensation
89.0
90.0
82.0
-1.1%
Buybacks
200
350
600
-42.9%
Dividends paid
573
569
577
+0.7%
Dividend per share
$1.94
$1.92
$1.91
+1.0%
Diluted shares, weighted
294m
293m
301m
+0.3%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
1,791
1,789
6,328
+0.1%
Non-controlling interest
3.0
3.0
2.0
0.0%
Redeemable equity
n/a
n/a
0.0
Debt
6,200
6,800
8,031
-8.8%
Operating lease liabilities
374
341
n/a
+9.7%
Finance lease liabilities
45.0
25.0
n/a
+80.0%
Other liabilities
36,040
31,808
26,602
+13.3%
Total liabilities and equity
44,453
40,766
40,963
+9.0%
Fixed assets
2,360
2,366
2,356
-0.3%
Goodwill
7,989
8,357
8,378
-4.4%
Intangible assets
2,105
2,918
3,430
-27.9%
Cash and equivalents
3,407
2,771
2,531
+23.0%
Receivables
9,103
8,264
8,448
+10.2%
Inventory
14,594
13,198
12,822
+10.6%
Other assets
4,895
2,892
2,998
+69.3%
Total assets
44,453
40,766
40,963
+9.0%
10-K for the year ended 30 June 2021, filed 16 August 2021: the filing.